![]() The Author(s), under exclusive licence to The Drug Information Association, Inc. ![]() The underlying size of large commercial claims databases offer opportunities for efficient evaluation of potential safety concerns, particularly for rare drug exposures, compared to traditional pregnancy registries.ĭiabetes Hyperlipidemia Migraine Pharmacovigilance Pregnancy. The 1629431614 NPI number is assigned to the healthcare provider VICTORIA CHIA, practice location address at. They can be pretty scary so in using everything at your disposal (including the. They are acting under the orders of the archipelago’s evil ruler Meavora and have taken Tchia’s father. The island that our heroine, Tchia, calls home has been invaded by strange fabric creatures called the Maano. Medication use among pregnant women was low and different from that among matched nonpregnant women. This webpage represents 1629431614 NPI record. Tchia keeps the beat while her father sings. Post-pregnancy, prescription fills increased to or exceeded pre-pregnancy levels, except antihypertensive and glucose-lowering medications, which increased during pregnancy. Most prescription fills were less common during pregnancy then pre-pregnancy. Medications of interest were less commonly used in the pregnancy cohort than in the matched nonpregnant cohort within each time period (e.g., 3.7% vs 13.1% antidepressant use in 1st trimester). Medication use (antidepressants, antihypertensives, sedatives, glucose-lowering medications, antiepileptics, antipsychotics, lipid-lowering medications) was abstracted from pharmacy claims 180 days before last menstrual period through 180 days postdelivery.Īmong 753,760 women in the general pregnancy population (including 73,268 migraine, 50,155 hyperlipidemia, and 8361 diabetes non-exclusive cohorts), antidepressants, antihypertensives, and sedatives were the most commonly used medications during pregnancy. This cohort study, using IBM MarketScan® Research Databases claims data, included women 10-54 years of age with pregnancy resulting in a liveborn infant between January 2010 and September 2015 and matched nonpregnant women. We examined medication fills in pregnant and nonpregnant women within select disease cohorts: general population, migraine, diabetes, and hyperlipidemia to explore the potential use of claims data to assess medication use and safety during pregnancy. Evaluation of drug safety during pregnancy is dependent on the number of exposed women during routine clinical practice with data available for analysis.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |